Squarepoint’s Inozyme Pharma INZY Stock Holding History

Squarepoint’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,927	Closed	-$192K	–	4655
2025 Q2	$192K	Buy	+47,927	New	+$119K	﹤0.01%	3992
2024 Q4	–	Sell	-28,093	Closed	-$147K	–	5262
2024 Q3	$147K	Buy	+28,093	New	+$146K	﹤0.01%	3785
2023 Q4	–	Sell	-42,607	Closed	-$179K	–	4243
2023 Q3	$179K	Buy	+42,607	New	+$217K	﹤0.01%	3445

Squarepoint's INZY Position: Q3 2025 in Review

Squarepoint sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 47,927 shares — an estimated $192K sold.

Squarepoint first reported a position in INZY in Q3 2023 and held it in 3 quarters. The position peaked at $192K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Squarepoint reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 47,927 Inozyme Pharma shares in Q3 2025, an estimated $192K.
Squarepoint first reported a position in Inozyme Pharma in Q3 2023 and held it in 3 quarters.
Squarepoint's Inozyme Pharma position peaked at $192K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.